Skip to content

Management of Thandagavatham (Lumbar Spondylosis) using Siddha medicine Maha Analurva Choornam

Clinical Evaluation of Maha Analurva Choornam in the management of Thandagavatham (Lumbar Spondylosis)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037209
Enrollment
30
Registered
2021-10-08
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M479- Spondylosis, unspecified

Interventions

Intervention1: Maha Analurva Choornam: Drug: Maha Analurva Choornam Dosage: 1.5 g twice a day Duration: 48 Days Adjuvent: Honey Control Intervention1: Nil: Nil

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with symptoms like pain and/or stiffness of the back, pain over the front of the thigh etc;Willing to give the blood samples for the investigation,Willing to take radiological investigations,Willing to sign the informed consent form

Exclusion criteria

Exclusion criteria: Patients with Spondylolisthesis,Ankylosing spondylitis,Spina bifida, Tuberculosis, Hypertension,Diabetes mellitus,Cardiac disease,Renal disease,osteomyelitis,Pregnant and lactating women,With severe or terminal illness like CA or HIV,Not willing to give blood samples for the investigation

Design outcomes

Primary

MeasureTime frame
The therapeutic effect of the Maha Analurva Choornam will be established using Warren grant magnuson scale.Timepoint: Fourty ninth day

Secondary

MeasureTime frame
The disability status of the patient before and after the treatment will be obtained The laboratory parameters before and after treatment will be documented. Prevalence of disease with respect to age,sex, occupation,habitat will be documented. Timepoint: Fourty ninth day

Countries

India

Contacts

Public ContactDr K Mahalakshmi

National Institute of Siddha

dr.vetha@gmail.com9894782366

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026